Sunday 23 January 2022

4 Stocks to Consider in midst of the HK Omicron Outbreak

 

Introduction

People who have been following news would know that Omicron has broke through Hong Kong's Covid-19 Defense. Previously known for its strict quarantine policy for foreign arrivals, Hong Kong has a 21 day quarantine period for foreign arrivals. While this has proved very effective, the breach in its Covid Defense came from reportedly 2 Cathay Flight Attendants who flouted isolation rules and was subsequently fired.



In Hong Kong, the fight against Covid has largely been a top-down approach. This is in the form of the government setting rules and measures to combat Covid. Unlike a couple of countries who has chosen to live with the virus, HK's approach is a Covid Zero approach as it aims to reopen its borders with China and possibly other countries when it has managed to achieve zero covid cases for a prolonged period of time.

Against the backdrop of the outbreak, HK government has initiated the following measures 

1) Urging Social Distancing and people to not go out unnecessarily.

2) Locking down estates for mandatory testing and asking citizens from blocks/areas that are identified as dangerous to undergo compulsory community testing.

3) Implementing measures such as Dining-in will be banned after 6pm, closing of bars, ktvs, cinemas. Also live performance has been banned.

4) Quarantining blocks when cases are too high in the block

5) Stepping up on vaccination by urging public to go for vaccination and increasing amount of vaccinations centres.

(Initiation of Compulsory testing in areas)
(Packed Testing Centre Queue)
(Queue to get tested)

As such, Testing, Quarantine and Vaccination will be key.


In lieu of the recent developments, 4 stocks have appeared to be interesting medical plays that one can consider in picking up.

1) Kato HK (HKEX: 2189)

-A company in the operations of aged care business. It derives most of its revenue from aged-care business. However it has took part in the operations involved with quarantine operations and this has allowed it to improve its profitability

- The company is involved in the quarantine operations at Asia-World Expo. This has propelled its revenue and profits. As such, it trades at an implied PE Ratio of 8.

- Revenue related to the quarantine operations 

1H 2020: 10.0 million HKD ( 8.7 % of total revenue)

2H 2020: 32.0 million HKD ( 22.8% of total revenue)

1H 2021: 30.9 million HKD ( 20.5% of total revenue)

- With news of quarantine facilities being packed. It is believed that Kato HK would continue to benefit.







2) Bamboos Health (HKEX: 2293)

- A company involved in the outsourcing of nursing staff, it has been able to grow its revenue by providing of services in the community vaccination centre.

- The company trades at an implied PE of 5.5

- The company is also involved in the vaccination drive by providing both Sinovac and Pfizer jabs.


(Sinovac jab offering)
(Pfizer jab offering)


3) Human Health (HKEX: 1419)

- A company involved in the medical services in Hong Kong, mainly via private clinics.

- The company has ventured into the administration of vaccine. This has resulted in the company to increase its revenue by 44% and turn in a profit from a loss making position in 2020.

- The company trades at an implied PE of 3

- As such, with the increased need to administer Covid 19 Vaccines and increased testing due to the recent outbreaks, this company is likely to benefit.

(Improve in revenue due to covid-19 related services)

(Human Health Mobile Vaccination Time-table)
(Human Health Mobile Vaccination Time-table)
(An example of a Human Health Collaboration with KingMed's Mobile Testing Point Truck)
(An example of a Human Health Mobile Testing Point Truck)
(Covid-19 Vaccination Truck by Human Health)


4) Town Health (Hkex: 3886)

- A company that has business in clinic operation in Hong Kong and China. It also has a lab for testing covid 19 results and is currently participating in HK's  community testing centre operations.

-In terms of financial results, the company has reported 2 years of unprofitability in the last 5 years. The company has some issues with getting back money owned to individuals via promissory notes and therefore had to write them off. 

-Nevertheless, the company has turned in a profit for 1H 2021 and declared a dividend policy of not less than 30% payout.

-The company trades at a book value of 0.67, with 47.5% of its market cap being cash. Unfortunately its PE is not accurate at there are present of one-off losses. However, a rough estimate assuming 1h results hold the same for 2h, it would be around 17.

(Example of a mobile vaccination booth by Town Health)
(2 Community Testing Centre out of 19 in Hong Kong is run by Town Health's Subsidiary Hong Kong Health Check & Medical Diagnostic Centre )
(Town Health running community vaccination centres)


Conclusion

HK has a population of 7.4 million. As such, assuming 3 jabs and a vaccination rate of 90% in the future, this equates to around 20 million jabs. Currently 10.7 million has been administered. Hence the vaccination run should run for another year unless a 4th jab or an add-on jab against omicron variant breaks out.

However, if the Covid 0 policy will still be the basis of HK's Covid Policy, then testing will definitely be key.

Among the 4 companies, i will only be somewhat interested in Human Health and Town Health.

Kato HK is still mainly an aged care business while Bambooshealth is more focused on staffing solutions.

Human Health has the cheaper valuations but Town Health has the more solid balance sheet. Although it has engaged in a couple of promissory notes that has ended up being written off.

The problem with Human Health is that their trade receivables have increased a lot in their recent result release and they have impaired roughly 4.5% of it. 

As such, both have their pros and cons. Which should happen as usual as it usually is close to impossible to find an ideal company with all pros and no cons.

No comments:

Post a Comment